Episurf Medical Q1: Slow quarter with eventful horizon
Research Update
2024-04-25
09:43
We note another quarter in which the operations have not yet translated into meaningful sales. We would like to point to two other significant events after the quarter: Its new distribution deal agreement and ongoing rights issue. We have preliminary updated our fair value range and await the completion of the rights issue for further adjustments.
JW
OB
John Westborg
Oscar Bergman
Disclosures and disclaimers